Objective:
To challenge the prevailing belief regarding the cessation of myopia control treatment based on refractive stabilization and highlight the potential risks of premature cessation.
Key Findings:
- Refractive stability does not equate to the cessation of axial elongation.
- Myopia progression can continue into the early 20s and beyond.
- Factors influencing myopia progression include age of onset, parental history, academic stress, and outdoor time.
- Premature cessation of treatment can lead to increased risk of myopia-related complications.
Interpretation:
Clinicians should adopt a more nuanced approach to myopia management, focusing on axial length stability, individual risk factors, and the importance of ongoing monitoring and lifestyle modifications rather than fixed age thresholds.
Limitations:
- The article does not provide specific data on the long-term outcomes of continued treatment versus cessation.
- Individual variability in myopia progression patterns may complicate treatment decisions.
- There is a lack of consensus on standardized treatment protocols for myopia management.
Conclusion:
A data-driven approach centered on axial stability and ongoing monitoring is essential for the long-term ocular health of patients with myopia.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.